Targeting Apoptosis to Treat Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|5|1|75-77

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.5, Iss.1, 2008-01, pp. : 75-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis

By Holèík Martin  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 3, 2004-06 ,pp. : 241-253

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of CB2 targeting in multiple sclerosis

By Docagne Fabian   Mestre Leyre   Loría Frida   Hernangómez Miriam   Correa Fernando   Guaza Carmen  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 185-195

Informa Healthcare

Access to resources Recommend Favorite

Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis

By Bar-Or Amit  

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 783-799

Adis International

Access to resources Recommend Favorite

Current and Future Therapies Targeting the Immune System in Multiple Sclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 3, 2014-03 ,pp. : 276-296

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Vascular Changes in Lesions in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 1, 2012-03 ,pp. : 7-14

Bentham Science Publishers

Access to resources Recommend Favorite